Show site search form

New Tissue Pathology and Diagnostic Oncology department opens at RPA Hospital

The new Tissue Pathology and Diagnostic Oncology department at Royal Prince Alfred (RPA) Hospital has officially opened, enhancing support for patients across Sydney.
This purpose-built facility is part of the hospital’s $940 million redevelopment and sets a new benchmark for pathology services across NSW with its latest design, equipment, and systems.

The development of the facility was a collaborative effort between Sydney Local Health District, NSW Health Pathology and Health Infrastructure.
Staff at RPA now have access to cutting-edge, future-focused facilities and technology. It includes additional floorspace, enabling staff to perform the latest cancer diagnostic testing and report on clinical cases, resulting in improved turnaround times and patient care.
Among its innovative features is a reticulated chemical system, the first-of-its-kind for NSW Health Pathology, as well as advanced technology allowing for real-time microscope displays through an integrated audio-visual system, also enabling remote training.
Additionally, the new location is now home to the Cytology team, supporting a more cohesive and efficient workflow.
The new RPA Tissue Pathology and Diagnostic Oncology Department replaces the existing facility at RPA Hospital. In 2023, the Department processed over 48,000 patient samples for a variety of cancer diagnostic tests.
More modern facilities for staff and patients are on the way as part of the RPA Hospital Redevelopment, which is continuing to progress.
The RPA Hospital Redevelopment project will further enhance the hospital’s infrastructure, including an expanded emergency department, state-of-the-art operating theatres, improved inpatient wards, and enhanced maternity services, with completion expected in 2028.
Back to the top of this page